Skip to main content
All lobbying filings

THE WASHINGTON TAX & PUBLIC POLICY GROUP

Lobbying for ALLIANCE FOR BIOPHARMACEUTICAL COMPETITIVENESS AND INNOVATION · Biopharmaceutical industry

 Filing Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 9, 2026
Income
$50,000.00
What the client paid this registrant for the period.
Client based in
District of Columbia

Official filing document

 Lobbyists on this filing 3
  • GREGORY NICKERSON
    Previously held: Tax Counsel, Ways and Means Committee; Staff Director, Ways and Means Select Revenue Measures Subcommittee
  • ZACHARY AUSTIN PRICE
    Previously held: Staff Assistant to Sen. Coats
  • JAMES MAX PEDROTTI New on this filing
    Previously held: Legislative Correspondent, Legislative Assistant, Senior Legislative Assistant, Legislative Director, Deputy Chief of Staff to Rep. Carol Miller

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1

Issues related to corporate and international taxation. Issues related to OECD Pillar 1 and Pillar 2 negotiations, agreements, implementation, and reporting related to the taxation of global income. Issues related to the taxation of intellectual property income. Issues related to foreign country tax administration and extraterritorial taxes. Issues related to IRC sections 11, 41 and 174, 45C, 55, 56A, and 59, 59A, 163(j), 250, 951A, 954(d) and 954(e), and 960(d)(2).

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem